Khan R reported that baseline MELD scores in patients with cirrhosis and ascites may predict SBP recently in the past few days.35 In addition, we determined that, compared with TBIL, NGAL may predict mortality with a sensitivity of 76.9% and a specificity of 45.1% in all SBP patients. This evidence concerns the gene LCN2 and Cirrhosis.